nodes	percent_of_prediction	percent_of_DWPC	metapath
Quinidine barbiturate—Musculoskeletal discomfort—Mycophenolic acid—systemic scleroderma	0.000822	0.000822	CcSEcCtD
Quinidine barbiturate—Confusional state—Lisinopril—systemic scleroderma	0.00082	0.00082	CcSEcCtD
Quinidine barbiturate—Gastrointestinal pain—Azathioprine—systemic scleroderma	0.000819	0.000819	CcSEcCtD
Quinidine barbiturate—Headache—Mometasone—systemic scleroderma	0.000819	0.000819	CcSEcCtD
Quinidine barbiturate—Tremor—Mycophenolate mofetil—systemic scleroderma	0.000818	0.000818	CcSEcCtD
Quinidine barbiturate—Gastrointestinal disorder—Leflunomide—systemic scleroderma	0.000817	0.000817	CcSEcCtD
Quinidine barbiturate—Oedema—Lisinopril—systemic scleroderma	0.000813	0.000813	CcSEcCtD
Quinidine barbiturate—Pruritus—Captopril—systemic scleroderma	0.000812	0.000812	CcSEcCtD
Quinidine barbiturate—Pain—Leflunomide—systemic scleroderma	0.000809	0.000809	CcSEcCtD
Quinidine barbiturate—Constipation—Leflunomide—systemic scleroderma	0.000809	0.000809	CcSEcCtD
Quinidine barbiturate—Dyspnoea—Mycophenolic acid—systemic scleroderma	0.000805	0.000805	CcSEcCtD
Quinidine barbiturate—Somnolence—Mycophenolic acid—systemic scleroderma	0.000802	0.000802	CcSEcCtD
Quinidine barbiturate—Agitation—Mycophenolate mofetil—systemic scleroderma	0.000802	0.000802	CcSEcCtD
Quinidine barbiturate—Shock—Lisinopril—systemic scleroderma	0.0008	0.0008	CcSEcCtD
Quinidine barbiturate—Angioedema—Mycophenolate mofetil—systemic scleroderma	0.000797	0.000797	CcSEcCtD
Quinidine barbiturate—Thrombocytopenia—Lisinopril—systemic scleroderma	0.000796	0.000796	CcSEcCtD
Quinidine barbiturate—Neutropenia—Prednisone—systemic scleroderma	0.000794	0.000794	CcSEcCtD
Quinidine barbiturate—Tachycardia—Lisinopril—systemic scleroderma	0.000793	0.000793	CcSEcCtD
Quinidine barbiturate—Body temperature increased—Azathioprine—systemic scleroderma	0.000792	0.000792	CcSEcCtD
Quinidine barbiturate—Abdominal pain—Azathioprine—systemic scleroderma	0.000792	0.000792	CcSEcCtD
Quinidine barbiturate—Skin disorder—Lisinopril—systemic scleroderma	0.00079	0.00079	CcSEcCtD
Quinidine barbiturate—Hyperhidrosis—Lisinopril—systemic scleroderma	0.000786	0.000786	CcSEcCtD
Quinidine barbiturate—Diarrhoea—Captopril—systemic scleroderma	0.000785	0.000785	CcSEcCtD
Quinidine barbiturate—Decreased appetite—Mycophenolic acid—systemic scleroderma	0.000785	0.000785	CcSEcCtD
Quinidine barbiturate—Vertigo—Mycophenolate mofetil—systemic scleroderma	0.000784	0.000784	CcSEcCtD
Quinidine barbiturate—Irritability—Methotrexate—systemic scleroderma	0.000784	0.000784	CcSEcCtD
Quinidine barbiturate—Syncope—Mycophenolate mofetil—systemic scleroderma	0.000783	0.000783	CcSEcCtD
Quinidine barbiturate—Leukopenia—Mycophenolate mofetil—systemic scleroderma	0.000781	0.000781	CcSEcCtD
Quinidine barbiturate—Feeling abnormal—Leflunomide—systemic scleroderma	0.00078	0.00078	CcSEcCtD
Quinidine barbiturate—Gastrointestinal disorder—Mycophenolic acid—systemic scleroderma	0.000779	0.000779	CcSEcCtD
Quinidine barbiturate—Mood swings—Methotrexate—systemic scleroderma	0.000778	0.000778	CcSEcCtD
Quinidine barbiturate—Nausea—Mometasone—systemic scleroderma	0.000776	0.000776	CcSEcCtD
Quinidine barbiturate—Anorexia—Lisinopril—systemic scleroderma	0.000775	0.000775	CcSEcCtD
Quinidine barbiturate—Gastrointestinal pain—Leflunomide—systemic scleroderma	0.000774	0.000774	CcSEcCtD
Quinidine barbiturate—Ataxia—Methotrexate—systemic scleroderma	0.000772	0.000772	CcSEcCtD
Quinidine barbiturate—Constipation—Mycophenolic acid—systemic scleroderma	0.000772	0.000772	CcSEcCtD
Quinidine barbiturate—Pain—Mycophenolic acid—systemic scleroderma	0.000772	0.000772	CcSEcCtD
Quinidine barbiturate—Palpitations—Mycophenolate mofetil—systemic scleroderma	0.000771	0.000771	CcSEcCtD
Quinidine barbiturate—Loss of consciousness—Mycophenolate mofetil—systemic scleroderma	0.000767	0.000767	CcSEcCtD
Quinidine barbiturate—Hypotension—Lisinopril—systemic scleroderma	0.00076	0.00076	CcSEcCtD
Quinidine barbiturate—Dizziness—Captopril—systemic scleroderma	0.000759	0.000759	CcSEcCtD
Quinidine barbiturate—Liver function test abnormal—Methotrexate—systemic scleroderma	0.000758	0.000758	CcSEcCtD
Quinidine barbiturate—Convulsion—Mycophenolate mofetil—systemic scleroderma	0.000756	0.000756	CcSEcCtD
Quinidine barbiturate—Urticaria—Leflunomide—systemic scleroderma	0.000752	0.000752	CcSEcCtD
Quinidine barbiturate—Body temperature increased—Leflunomide—systemic scleroderma	0.000748	0.000748	CcSEcCtD
Quinidine barbiturate—Abdominal pain—Leflunomide—systemic scleroderma	0.000748	0.000748	CcSEcCtD
Quinidine barbiturate—Feeling abnormal—Mycophenolic acid—systemic scleroderma	0.000744	0.000744	CcSEcCtD
Quinidine barbiturate—Myalgia—Mycophenolate mofetil—systemic scleroderma	0.000743	0.000743	CcSEcCtD
Quinidine barbiturate—Arthralgia—Mycophenolate mofetil—systemic scleroderma	0.000743	0.000743	CcSEcCtD
Quinidine barbiturate—Chest pain—Mycophenolate mofetil—systemic scleroderma	0.000743	0.000743	CcSEcCtD
Quinidine barbiturate—Breast disorder—Methotrexate—systemic scleroderma	0.000742	0.000742	CcSEcCtD
Quinidine barbiturate—Musculoskeletal discomfort—Lisinopril—systemic scleroderma	0.000741	0.000741	CcSEcCtD
Quinidine barbiturate—Anxiety—Mycophenolate mofetil—systemic scleroderma	0.00074	0.00074	CcSEcCtD
Quinidine barbiturate—Toxic epidermal necrolysis—Methotrexate—systemic scleroderma	0.000739	0.000739	CcSEcCtD
Quinidine barbiturate—Hypersensitivity—Azathioprine—systemic scleroderma	0.000738	0.000738	CcSEcCtD
Quinidine barbiturate—Gastrointestinal pain—Mycophenolic acid—systemic scleroderma	0.000738	0.000738	CcSEcCtD
Quinidine barbiturate—Unspecified disorder of skin and subcutaneous tissue—Mycophenolate mofetil—systemic scleroderma	0.000738	0.000738	CcSEcCtD
Quinidine barbiturate—Vomiting—Captopril—systemic scleroderma	0.00073	0.00073	CcSEcCtD
Quinidine barbiturate—Dyspnoea—Lisinopril—systemic scleroderma	0.000725	0.000725	CcSEcCtD
Quinidine barbiturate—Rash—Captopril—systemic scleroderma	0.000724	0.000724	CcSEcCtD
Quinidine barbiturate—Dermatitis—Captopril—systemic scleroderma	0.000723	0.000723	CcSEcCtD
Quinidine barbiturate—Somnolence—Lisinopril—systemic scleroderma	0.000723	0.000723	CcSEcCtD
Quinidine barbiturate—Headache—Captopril—systemic scleroderma	0.000719	0.000719	CcSEcCtD
Quinidine barbiturate—Confusional state—Mycophenolate mofetil—systemic scleroderma	0.000718	0.000718	CcSEcCtD
Quinidine barbiturate—Abdominal pain—Mycophenolic acid—systemic scleroderma	0.000713	0.000713	CcSEcCtD
Quinidine barbiturate—Body temperature increased—Mycophenolic acid—systemic scleroderma	0.000713	0.000713	CcSEcCtD
Quinidine barbiturate—Oedema—Mycophenolate mofetil—systemic scleroderma	0.000712	0.000712	CcSEcCtD
Quinidine barbiturate—Asthma—Methotrexate—systemic scleroderma	0.00071	0.00071	CcSEcCtD
Quinidine barbiturate—Decreased appetite—Lisinopril—systemic scleroderma	0.000707	0.000707	CcSEcCtD
Quinidine barbiturate—Gastrointestinal disorder—Lisinopril—systemic scleroderma	0.000702	0.000702	CcSEcCtD
Quinidine barbiturate—Shock—Mycophenolate mofetil—systemic scleroderma	0.000701	0.000701	CcSEcCtD
Quinidine barbiturate—Nervous system disorder—Mycophenolate mofetil—systemic scleroderma	0.000698	0.000698	CcSEcCtD
Quinidine barbiturate—Thrombocytopenia—Mycophenolate mofetil—systemic scleroderma	0.000697	0.000697	CcSEcCtD
Quinidine barbiturate—Hypersensitivity—Leflunomide—systemic scleroderma	0.000697	0.000697	CcSEcCtD
Quinidine barbiturate—Constipation—Lisinopril—systemic scleroderma	0.000695	0.000695	CcSEcCtD
Quinidine barbiturate—Pain—Lisinopril—systemic scleroderma	0.000695	0.000695	CcSEcCtD
Quinidine barbiturate—Tachycardia—Mycophenolate mofetil—systemic scleroderma	0.000695	0.000695	CcSEcCtD
Quinidine barbiturate—Skin disorder—Mycophenolate mofetil—systemic scleroderma	0.000692	0.000692	CcSEcCtD
Quinidine barbiturate—Bradycardia—Prednisone—systemic scleroderma	0.000692	0.000692	CcSEcCtD
Quinidine barbiturate—Hyperhidrosis—Mycophenolate mofetil—systemic scleroderma	0.000689	0.000689	CcSEcCtD
Quinidine barbiturate—Diarrhoea—Azathioprine—systemic scleroderma	0.000685	0.000685	CcSEcCtD
Quinidine barbiturate—Haemoglobin—Prednisone—systemic scleroderma	0.000683	0.000683	CcSEcCtD
Quinidine barbiturate—Nausea—Captopril—systemic scleroderma	0.000682	0.000682	CcSEcCtD
Quinidine barbiturate—Haemorrhage—Prednisone—systemic scleroderma	0.00068	0.00068	CcSEcCtD
Quinidine barbiturate—Anorexia—Mycophenolate mofetil—systemic scleroderma	0.000679	0.000679	CcSEcCtD
Quinidine barbiturate—Asthenia—Leflunomide—systemic scleroderma	0.000679	0.000679	CcSEcCtD
Quinidine barbiturate—Hallucination—Prednisone—systemic scleroderma	0.000676	0.000676	CcSEcCtD
Quinidine barbiturate—Pancytopenia—Methotrexate—systemic scleroderma	0.000674	0.000674	CcSEcCtD
Quinidine barbiturate—Feeling abnormal—Lisinopril—systemic scleroderma	0.00067	0.00067	CcSEcCtD
Quinidine barbiturate—Pruritus—Leflunomide—systemic scleroderma	0.000669	0.000669	CcSEcCtD
Quinidine barbiturate—Hypotension—Mycophenolate mofetil—systemic scleroderma	0.000666	0.000666	CcSEcCtD
Quinidine barbiturate—Gastrointestinal pain—Lisinopril—systemic scleroderma	0.000665	0.000665	CcSEcCtD
Quinidine barbiturate—Neutropenia—Methotrexate—systemic scleroderma	0.000663	0.000663	CcSEcCtD
Quinidine barbiturate—Dizziness—Azathioprine—systemic scleroderma	0.000662	0.000662	CcSEcCtD
Quinidine barbiturate—Musculoskeletal discomfort—Mycophenolate mofetil—systemic scleroderma	0.000649	0.000649	CcSEcCtD
Quinidine barbiturate—Photosensitivity reaction—Methotrexate—systemic scleroderma	0.000648	0.000648	CcSEcCtD
Quinidine barbiturate—Asthenia—Mycophenolic acid—systemic scleroderma	0.000648	0.000648	CcSEcCtD
Quinidine barbiturate—Diarrhoea—Leflunomide—systemic scleroderma	0.000647	0.000647	CcSEcCtD
Quinidine barbiturate—Urticaria—Lisinopril—systemic scleroderma	0.000646	0.000646	CcSEcCtD
Quinidine barbiturate—Abdominal pain—Lisinopril—systemic scleroderma	0.000643	0.000643	CcSEcCtD
Quinidine barbiturate—Body temperature increased—Lisinopril—systemic scleroderma	0.000643	0.000643	CcSEcCtD
Quinidine barbiturate—Pruritus—Mycophenolic acid—systemic scleroderma	0.000639	0.000639	CcSEcCtD
Quinidine barbiturate—Vomiting—Azathioprine—systemic scleroderma	0.000637	0.000637	CcSEcCtD
Quinidine barbiturate—Eye disorder—Prednisone—systemic scleroderma	0.000635	0.000635	CcSEcCtD
Quinidine barbiturate—Dyspnoea—Mycophenolate mofetil—systemic scleroderma	0.000635	0.000635	CcSEcCtD
Quinidine barbiturate—Somnolence—Mycophenolate mofetil—systemic scleroderma	0.000633	0.000633	CcSEcCtD
Quinidine barbiturate—Drowsiness—Methotrexate—systemic scleroderma	0.000633	0.000633	CcSEcCtD
Quinidine barbiturate—Rash—Azathioprine—systemic scleroderma	0.000632	0.000632	CcSEcCtD
Quinidine barbiturate—Dermatitis—Azathioprine—systemic scleroderma	0.000631	0.000631	CcSEcCtD
Quinidine barbiturate—Flushing—Prednisone—systemic scleroderma	0.000631	0.000631	CcSEcCtD
Quinidine barbiturate—Headache—Azathioprine—systemic scleroderma	0.000628	0.000628	CcSEcCtD
Quinidine barbiturate—Stevens-Johnson syndrome—Methotrexate—systemic scleroderma	0.000627	0.000627	CcSEcCtD
Quinidine barbiturate—Dizziness—Leflunomide—systemic scleroderma	0.000626	0.000626	CcSEcCtD
Quinidine barbiturate—Renal failure—Methotrexate—systemic scleroderma	0.000622	0.000622	CcSEcCtD
Quinidine barbiturate—Decreased appetite—Mycophenolate mofetil—systemic scleroderma	0.000619	0.000619	CcSEcCtD
Quinidine barbiturate—Diarrhoea—Mycophenolic acid—systemic scleroderma	0.000617	0.000617	CcSEcCtD
Quinidine barbiturate—Gastrointestinal disorder—Mycophenolate mofetil—systemic scleroderma	0.000615	0.000615	CcSEcCtD
Quinidine barbiturate—Immune system disorder—Prednisone—systemic scleroderma	0.000614	0.000614	CcSEcCtD
Quinidine barbiturate—Constipation—Mycophenolate mofetil—systemic scleroderma	0.000609	0.000609	CcSEcCtD
Quinidine barbiturate—Pain—Mycophenolate mofetil—systemic scleroderma	0.000609	0.000609	CcSEcCtD
Quinidine barbiturate—Sweating—Methotrexate—systemic scleroderma	0.000606	0.000606	CcSEcCtD
Quinidine barbiturate—Vomiting—Leflunomide—systemic scleroderma	0.000601	0.000601	CcSEcCtD
Quinidine barbiturate—Hypersensitivity—Lisinopril—systemic scleroderma	0.000599	0.000599	CcSEcCtD
Quinidine barbiturate—Dizziness—Mycophenolic acid—systemic scleroderma	0.000597	0.000597	CcSEcCtD
Quinidine barbiturate—Rash—Leflunomide—systemic scleroderma	0.000596	0.000596	CcSEcCtD
Quinidine barbiturate—Dermatitis—Leflunomide—systemic scleroderma	0.000596	0.000596	CcSEcCtD
Quinidine barbiturate—Mental disorder—Prednisone—systemic scleroderma	0.000595	0.000595	CcSEcCtD
Quinidine barbiturate—Nausea—Azathioprine—systemic scleroderma	0.000595	0.000595	CcSEcCtD
Quinidine barbiturate—Headache—Leflunomide—systemic scleroderma	0.000593	0.000593	CcSEcCtD
Quinidine barbiturate—Erythema—Prednisone—systemic scleroderma	0.000592	0.000592	CcSEcCtD
Quinidine barbiturate—Malnutrition—Prednisone—systemic scleroderma	0.000592	0.000592	CcSEcCtD
Quinidine barbiturate—Agranulocytosis—Methotrexate—systemic scleroderma	0.00059	0.00059	CcSEcCtD
Quinidine barbiturate—Feeling abnormal—Mycophenolate mofetil—systemic scleroderma	0.000587	0.000587	CcSEcCtD
Quinidine barbiturate—Asthenia—Lisinopril—systemic scleroderma	0.000583	0.000583	CcSEcCtD
Quinidine barbiturate—Gastrointestinal pain—Mycophenolate mofetil—systemic scleroderma	0.000582	0.000582	CcSEcCtD
Quinidine barbiturate—Pruritus—Lisinopril—systemic scleroderma	0.000575	0.000575	CcSEcCtD
Quinidine barbiturate—Vomiting—Mycophenolic acid—systemic scleroderma	0.000574	0.000574	CcSEcCtD
Quinidine barbiturate—Haemoglobin—Methotrexate—systemic scleroderma	0.000571	0.000571	CcSEcCtD
Quinidine barbiturate—Rash—Mycophenolic acid—systemic scleroderma	0.000569	0.000569	CcSEcCtD
Quinidine barbiturate—Dermatitis—Mycophenolic acid—systemic scleroderma	0.000569	0.000569	CcSEcCtD
Quinidine barbiturate—Hepatitis—Methotrexate—systemic scleroderma	0.000568	0.000568	CcSEcCtD
Quinidine barbiturate—Haemorrhage—Methotrexate—systemic scleroderma	0.000568	0.000568	CcSEcCtD
Quinidine barbiturate—Urticaria—Mycophenolate mofetil—systemic scleroderma	0.000566	0.000566	CcSEcCtD
Quinidine barbiturate—Headache—Mycophenolic acid—systemic scleroderma	0.000565	0.000565	CcSEcCtD
Quinidine barbiturate—Abdominal pain—Mycophenolate mofetil—systemic scleroderma	0.000563	0.000563	CcSEcCtD
Quinidine barbiturate—Body temperature increased—Mycophenolate mofetil—systemic scleroderma	0.000563	0.000563	CcSEcCtD
Quinidine barbiturate—Nausea—Leflunomide—systemic scleroderma	0.000562	0.000562	CcSEcCtD
Quinidine barbiturate—Urinary tract disorder—Methotrexate—systemic scleroderma	0.000561	0.000561	CcSEcCtD
Quinidine barbiturate—Vision blurred—Prednisone—systemic scleroderma	0.000557	0.000557	CcSEcCtD
Quinidine barbiturate—Urethral disorder—Methotrexate—systemic scleroderma	0.000557	0.000557	CcSEcCtD
Quinidine barbiturate—Diarrhoea—Lisinopril—systemic scleroderma	0.000556	0.000556	CcSEcCtD
Quinidine barbiturate—Visual impairment—Methotrexate—systemic scleroderma	0.000547	0.000547	CcSEcCtD
Quinidine barbiturate—Agitation—Prednisone—systemic scleroderma	0.000544	0.000544	CcSEcCtD
Quinidine barbiturate—Angioedema—Prednisone—systemic scleroderma	0.000541	0.000541	CcSEcCtD
Quinidine barbiturate—Dizziness—Lisinopril—systemic scleroderma	0.000538	0.000538	CcSEcCtD
Quinidine barbiturate—Erythema multiforme—Methotrexate—systemic scleroderma	0.000537	0.000537	CcSEcCtD
Quinidine barbiturate—Nausea—Mycophenolic acid—systemic scleroderma	0.000536	0.000536	CcSEcCtD
Quinidine barbiturate—Vertigo—Prednisone—systemic scleroderma	0.000531	0.000531	CcSEcCtD
Quinidine barbiturate—Eye disorder—Methotrexate—systemic scleroderma	0.000531	0.000531	CcSEcCtD
Quinidine barbiturate—Syncope—Prednisone—systemic scleroderma	0.00053	0.00053	CcSEcCtD
Quinidine barbiturate—Tinnitus—Methotrexate—systemic scleroderma	0.000529	0.000529	CcSEcCtD
Quinidine barbiturate—Cardiac disorder—Methotrexate—systemic scleroderma	0.000527	0.000527	CcSEcCtD
Quinidine barbiturate—Hypersensitivity—Mycophenolate mofetil—systemic scleroderma	0.000525	0.000525	CcSEcCtD
Quinidine barbiturate—Loss of consciousness—Prednisone—systemic scleroderma	0.00052	0.00052	CcSEcCtD
Quinidine barbiturate—Vomiting—Lisinopril—systemic scleroderma	0.000517	0.000517	CcSEcCtD
Quinidine barbiturate—Immune system disorder—Methotrexate—systemic scleroderma	0.000513	0.000513	CcSEcCtD
Quinidine barbiturate—Rash—Lisinopril—systemic scleroderma	0.000513	0.000513	CcSEcCtD
Quinidine barbiturate—Convulsion—Prednisone—systemic scleroderma	0.000513	0.000513	CcSEcCtD
Quinidine barbiturate—Dermatitis—Lisinopril—systemic scleroderma	0.000512	0.000512	CcSEcCtD
Quinidine barbiturate—Mediastinal disorder—Methotrexate—systemic scleroderma	0.000512	0.000512	CcSEcCtD
Quinidine barbiturate—Asthenia—Mycophenolate mofetil—systemic scleroderma	0.000511	0.000511	CcSEcCtD
Quinidine barbiturate—Chills—Methotrexate—systemic scleroderma	0.00051	0.00051	CcSEcCtD
Quinidine barbiturate—Headache—Lisinopril—systemic scleroderma	0.000509	0.000509	CcSEcCtD
Quinidine barbiturate—Pruritus—Mycophenolate mofetil—systemic scleroderma	0.000504	0.000504	CcSEcCtD
Quinidine barbiturate—Arthralgia—Prednisone—systemic scleroderma	0.000504	0.000504	CcSEcCtD
Quinidine barbiturate—Myalgia—Prednisone—systemic scleroderma	0.000504	0.000504	CcSEcCtD
Quinidine barbiturate—Anxiety—Prednisone—systemic scleroderma	0.000502	0.000502	CcSEcCtD
Quinidine barbiturate—Unspecified disorder of skin and subcutaneous tissue—Prednisone—systemic scleroderma	0.0005	0.0005	CcSEcCtD
Quinidine barbiturate—Mental disorder—Methotrexate—systemic scleroderma	0.000498	0.000498	CcSEcCtD
Quinidine barbiturate—Erythema—Methotrexate—systemic scleroderma	0.000494	0.000494	CcSEcCtD
Quinidine barbiturate—Malnutrition—Methotrexate—systemic scleroderma	0.000494	0.000494	CcSEcCtD
Quinidine barbiturate—Diarrhoea—Mycophenolate mofetil—systemic scleroderma	0.000487	0.000487	CcSEcCtD
Quinidine barbiturate—Nausea—Lisinopril—systemic scleroderma	0.000483	0.000483	CcSEcCtD
Quinidine barbiturate—Oedema—Prednisone—systemic scleroderma	0.000483	0.000483	CcSEcCtD
Quinidine barbiturate—Shock—Prednisone—systemic scleroderma	0.000475	0.000475	CcSEcCtD
Quinidine barbiturate—Nervous system disorder—Prednisone—systemic scleroderma	0.000473	0.000473	CcSEcCtD
Quinidine barbiturate—Tachycardia—Prednisone—systemic scleroderma	0.000471	0.000471	CcSEcCtD
Quinidine barbiturate—Dizziness—Mycophenolate mofetil—systemic scleroderma	0.000471	0.000471	CcSEcCtD
Quinidine barbiturate—Skin disorder—Prednisone—systemic scleroderma	0.000469	0.000469	CcSEcCtD
Quinidine barbiturate—Hyperhidrosis—Prednisone—systemic scleroderma	0.000467	0.000467	CcSEcCtD
Quinidine barbiturate—Vision blurred—Methotrexate—systemic scleroderma	0.000466	0.000466	CcSEcCtD
Quinidine barbiturate—Anorexia—Prednisone—systemic scleroderma	0.00046	0.00046	CcSEcCtD
Quinidine barbiturate—Vomiting—Mycophenolate mofetil—systemic scleroderma	0.000453	0.000453	CcSEcCtD
Quinidine barbiturate—Rash—Mycophenolate mofetil—systemic scleroderma	0.000449	0.000449	CcSEcCtD
Quinidine barbiturate—Dermatitis—Mycophenolate mofetil—systemic scleroderma	0.000449	0.000449	CcSEcCtD
Quinidine barbiturate—Headache—Mycophenolate mofetil—systemic scleroderma	0.000446	0.000446	CcSEcCtD
Quinidine barbiturate—Vertigo—Methotrexate—systemic scleroderma	0.000444	0.000444	CcSEcCtD
Quinidine barbiturate—Leukopenia—Methotrexate—systemic scleroderma	0.000443	0.000443	CcSEcCtD
Quinidine barbiturate—Musculoskeletal discomfort—Prednisone—systemic scleroderma	0.00044	0.00044	CcSEcCtD
Quinidine barbiturate—Convulsion—Methotrexate—systemic scleroderma	0.000428	0.000428	CcSEcCtD
Quinidine barbiturate—Nausea—Mycophenolate mofetil—systemic scleroderma	0.000423	0.000423	CcSEcCtD
Quinidine barbiturate—Chest pain—Methotrexate—systemic scleroderma	0.000421	0.000421	CcSEcCtD
Quinidine barbiturate—Myalgia—Methotrexate—systemic scleroderma	0.000421	0.000421	CcSEcCtD
Quinidine barbiturate—Arthralgia—Methotrexate—systemic scleroderma	0.000421	0.000421	CcSEcCtD
Quinidine barbiturate—Decreased appetite—Prednisone—systemic scleroderma	0.00042	0.00042	CcSEcCtD
Quinidine barbiturate—Unspecified disorder of skin and subcutaneous tissue—Methotrexate—systemic scleroderma	0.000418	0.000418	CcSEcCtD
Quinidine barbiturate—Constipation—Prednisone—systemic scleroderma	0.000413	0.000413	CcSEcCtD
Quinidine barbiturate—Confusional state—Methotrexate—systemic scleroderma	0.000407	0.000407	CcSEcCtD
Quinidine barbiturate—Feeling abnormal—Prednisone—systemic scleroderma	0.000398	0.000398	CcSEcCtD
Quinidine barbiturate—Nervous system disorder—Methotrexate—systemic scleroderma	0.000396	0.000396	CcSEcCtD
Quinidine barbiturate—Thrombocytopenia—Methotrexate—systemic scleroderma	0.000395	0.000395	CcSEcCtD
Quinidine barbiturate—Gastrointestinal pain—Prednisone—systemic scleroderma	0.000395	0.000395	CcSEcCtD
Quinidine barbiturate—Skin disorder—Methotrexate—systemic scleroderma	0.000392	0.000392	CcSEcCtD
Quinidine barbiturate—Hyperhidrosis—Methotrexate—systemic scleroderma	0.00039	0.00039	CcSEcCtD
Quinidine barbiturate—Anorexia—Methotrexate—systemic scleroderma	0.000385	0.000385	CcSEcCtD
Quinidine barbiturate—Urticaria—Prednisone—systemic scleroderma	0.000384	0.000384	CcSEcCtD
Quinidine barbiturate—Body temperature increased—Prednisone—systemic scleroderma	0.000382	0.000382	CcSEcCtD
Quinidine barbiturate—Abdominal pain—Prednisone—systemic scleroderma	0.000382	0.000382	CcSEcCtD
Quinidine barbiturate—Hypotension—Methotrexate—systemic scleroderma	0.000377	0.000377	CcSEcCtD
Quinidine barbiturate—Musculoskeletal discomfort—Methotrexate—systemic scleroderma	0.000368	0.000368	CcSEcCtD
Quinidine barbiturate—Dyspnoea—Methotrexate—systemic scleroderma	0.00036	0.00036	CcSEcCtD
Quinidine barbiturate—Somnolence—Methotrexate—systemic scleroderma	0.000359	0.000359	CcSEcCtD
Quinidine barbiturate—Hypersensitivity—Prednisone—systemic scleroderma	0.000356	0.000356	CcSEcCtD
Quinidine barbiturate—Decreased appetite—Methotrexate—systemic scleroderma	0.000351	0.000351	CcSEcCtD
Quinidine barbiturate—Gastrointestinal disorder—Methotrexate—systemic scleroderma	0.000348	0.000348	CcSEcCtD
Quinidine barbiturate—Asthenia—Prednisone—systemic scleroderma	0.000346	0.000346	CcSEcCtD
Quinidine barbiturate—Pain—Methotrexate—systemic scleroderma	0.000345	0.000345	CcSEcCtD
Quinidine barbiturate—Pruritus—Prednisone—systemic scleroderma	0.000342	0.000342	CcSEcCtD
Quinidine barbiturate—Feeling abnormal—Methotrexate—systemic scleroderma	0.000332	0.000332	CcSEcCtD
Quinidine barbiturate—Diarrhoea—Prednisone—systemic scleroderma	0.00033	0.00033	CcSEcCtD
Quinidine barbiturate—Gastrointestinal pain—Methotrexate—systemic scleroderma	0.00033	0.00033	CcSEcCtD
Quinidine barbiturate—Urticaria—Methotrexate—systemic scleroderma	0.000321	0.000321	CcSEcCtD
Quinidine barbiturate—Dizziness—Prednisone—systemic scleroderma	0.000319	0.000319	CcSEcCtD
Quinidine barbiturate—Abdominal pain—Methotrexate—systemic scleroderma	0.000319	0.000319	CcSEcCtD
Quinidine barbiturate—Body temperature increased—Methotrexate—systemic scleroderma	0.000319	0.000319	CcSEcCtD
Quinidine barbiturate—Vomiting—Prednisone—systemic scleroderma	0.000307	0.000307	CcSEcCtD
Quinidine barbiturate—Rash—Prednisone—systemic scleroderma	0.000304	0.000304	CcSEcCtD
Quinidine barbiturate—Dermatitis—Prednisone—systemic scleroderma	0.000304	0.000304	CcSEcCtD
Quinidine barbiturate—Headache—Prednisone—systemic scleroderma	0.000302	0.000302	CcSEcCtD
Quinidine barbiturate—Hypersensitivity—Methotrexate—systemic scleroderma	0.000297	0.000297	CcSEcCtD
Quinidine barbiturate—Asthenia—Methotrexate—systemic scleroderma	0.000289	0.000289	CcSEcCtD
Quinidine barbiturate—Nausea—Prednisone—systemic scleroderma	0.000287	0.000287	CcSEcCtD
Quinidine barbiturate—Pruritus—Methotrexate—systemic scleroderma	0.000285	0.000285	CcSEcCtD
Quinidine barbiturate—Diarrhoea—Methotrexate—systemic scleroderma	0.000276	0.000276	CcSEcCtD
Quinidine barbiturate—Dizziness—Methotrexate—systemic scleroderma	0.000267	0.000267	CcSEcCtD
Quinidine barbiturate—Vomiting—Methotrexate—systemic scleroderma	0.000257	0.000257	CcSEcCtD
Quinidine barbiturate—Rash—Methotrexate—systemic scleroderma	0.000254	0.000254	CcSEcCtD
Quinidine barbiturate—Dermatitis—Methotrexate—systemic scleroderma	0.000254	0.000254	CcSEcCtD
Quinidine barbiturate—Headache—Methotrexate—systemic scleroderma	0.000253	0.000253	CcSEcCtD
Quinidine barbiturate—Nausea—Methotrexate—systemic scleroderma	0.00024	0.00024	CcSEcCtD
